スポンサーリンク
Research Institute for Hepatology, Toranomon Branch Hospital | 論文
- Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
- Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
- Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
- Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
- Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
- Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
- Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
- Clinical features of hepatitis B virus genotype A in Japanese patients
- Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C
- 5'Untranslated Region of the HSP 18.2 Gene Contributes to Efficient Translation in Plant Cells(PLANT BIOTECHNOLOGY)
- Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks
- Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment
- The 5'-Untranslated Region of the Tobacco Alcohol Dehydrogenase Gene Functions as an Effective Translational Enhancer in Plant(PLANT BIOTECHNOLOGY)
- Natural Human Interferon β Plus Ribavirin Combination Therapy in Japanese Patients Infected with Hepatitis C Virus and a High Viral Load
- Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus
- Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan
- Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection
- Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B : results from a nine-year longitudinal study